Physician profile
Abdul Mohammed
NPI 1659820520
$1,555.05
in general payments reported to CMS, 2019-2025
8 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.83 · 2023: $177 · 2024: $1,125 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711 · Travel and Lodging: $652 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.88 |
| Travel and Lodging | $652.34 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $814.11 | 2024 | Olympus, Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655 |
| Abbvie INC. | $261.11 | 2023-2025 | |
| Boston Scientific Corporation | $159.82 | 2022-2025 | Axonics |
| Janssen Biotech, INC. | $157.99 | 2022-2024 | Stelara |
| Fujifilm Healthcare Americas Corporation | $85.00 | 2024 | |
| Genzyme Corporation | $34.36 | 2023 | |
| Medtronic, INC. | $21.43 | 2023 | Barrx |
| Regeneron Healthcare Solutions, INC. | $21.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.